Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating psilocybin-enhanced psychotherapy for methamphetamine use disorder. The broader condition is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Portland VA Research Foundation, Inc | Conditions: Amphetamine-Related Disorders | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING